Asia Pacific Liposome Drug Delivery Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Liposome Drug Delivery Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Liposome Drug Delivery Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Liposome Drug Delivery in Cancer Therapy

5.2 Market Opportunities

5.2.1 Research & Development (R&D) Activities

5.3 Future Trends

5.3.1 Fast regulatory approval

5.4 Impact of Drivers and Restraints

6. Asia Pacific Liposome Drug Delivery Market Regional Analysis

6.1 Asia Pacific Liposome Drug Delivery Market Overview

6.2 Asia Pacific Liposome Drug Delivery Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Liposome Drug Delivery Market Forecast Analysis

7. Asia Pacific Liposome Drug Delivery Market Analysis – by Product

7.1 Liposomal Doxorubicin

7.1.1 Overview
7.1.2 Liposomal Doxorubicin: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Liposomal Paclitaxel

7.2.1 Overview
7.2.2 Liposomal Paclitaxel: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Liposomal Amphotericin B

7.3.1 Overview
7.3.2 Liposomal Amphotericin B: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Liposome Drug Delivery Market Analysis – by Technology

8.1 Stealth Liposome Technology

8.1.1 Overview
8.1.2 Stealth Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Non-PEGylated Liposome Technology

8.2.1 Overview
8.2.2 Non-PEGylated Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.3 DepoFoam Liposome Technology

8.3.1 Overview
8.3.2 DepoFoam Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Lysolipid Thermally Sensitive Liposome Technology

8.4.1 Overview
8.4.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Liposome Drug Delivery Market Analysis – by Application

9.1 Fungal Diseases

9.1.1 Overview
9.1.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Cancer Therapy

9.2.1 Overview
9.2.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Pain Management

9.3.1 Overview
9.3.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Viral Vaccines

9.4.1 Overview
9.4.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Photodynamic Therapy

9.5.1 Overview
9.5.2 Lysolipid Thermally Sensitive Liposome Technology: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10. Asia Pacific Liposome Drug Delivery Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Liposome Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.1.1.1.2 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.1.3 China: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.1.1.2 India: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.1.1.2.2 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.2.3 India: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.1.1.3 Japan: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.3.3 Japan: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.1.1.4 Australia: Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.1.1.4.2 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.4.3 Australia: Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Product
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Liposome Drug Delivery Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Liposome Drug Delivery Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ASTELLAS PHARMA INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 JOHNSON AND JOHNSON SERVICES, INC.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 LUYE PHARMA GROUP

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Ipsen Pharma

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Gilead Sciences, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Celsion, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights